Coste Catherine bought BLFS
March 18, 2025 · Form 4 insider transaction
Coste Catherine bought 5,701 shares of BioLife Solutions Inc, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,701
Price
N/A
Total value
N/A
InsiderCoste Catherine
RoleDirector
CompanyBioLife Solutions Inc (BLFS)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 18, 2025
Filing dateMarch 20, 2025
Shares owned after5,701
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the measurement date of 01-02-2025.